UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041690
Receipt number R000047550
Scientific Title Effects of stimulation frequency in peripheral nerve stimulation on the primary motor cortex excitability in healthy subjects: a crossover randomized controlled trial
Date of disclosure of the study information 2020/09/05
Last modified on 2022/03/14 18:12:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of stimulation frequency in peripheral nerve stimulation on the primary motor cortex excitability in healthy subjects: a crossover randomized controlled trial

Acronym

Effects of stimulation frequency in peripheral nerve stimulation on the primary motor cortex excitability in healthy subjects: a crossover randomized controlled trial

Scientific Title

Effects of stimulation frequency in peripheral nerve stimulation on the primary motor cortex excitability in healthy subjects: a crossover randomized controlled trial

Scientific Title:Acronym

Effects of stimulation frequency in peripheral nerve stimulation on the primary motor cortex excitability in healthy subjects: a crossover randomized controlled trial

Region

Japan


Condition

Condition

Healthy subjects

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine whether stimulation at a frequency of 100 Hz in peripheral electrical stimulation above the sensory threshold can increase the primary motor cortex's excitability earlier than at a frequency of 10 Hz.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Motor evoked potentials before stimulation, at 15, 30, 45, 60, 65, 70, and 75 minutes after stimulation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Peripheral electrical stimulation

Frequency: 100 Hz
Intensity: above sensory threshold
Pulse width: 250 microsecond
Stimulation time: 60 minutes

Interventions/Control_2

Peripheral electrical stimulation

Frequency: 10 Hz
Intensity: above sensory threshold
Pulse width: 250 microsecond
Stimulation time: 60 minutes

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Age: from 20 to 60 years old
2) Obtaining agreement to this study

Key exclusion criteria

1) A history of orthopedic disease
2) A history of neurological diseases
3) Contraindicated to transcranial magnetic stimulation
4) Contraindications to peripheral electrical stimulation
5) Persons are deemed unsuitable by researchers or physicians

Target sample size

14


Research contact person

Name of lead principal investigator

1st name Daisuke
Middle name
Last name Kubo

Organization

Tokai university hospital

Division name

Department of rehabilitation services

Zip code

259-1193

Address

143 Shimokasuya, Isehara city, KANAGAWA

TEL

0463-93-1121

Email

d.bokukubo@tokai.ac.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Kubo

Organization

Tokai university hospital

Division name

Department of rehabilitation services

Zip code

259-1193

Address

143 Shimokasuya, Isehara city, KANAGAWA

TEL

0463-93-1121

Homepage URL


Email

d.bokukubo@tokai.ac.jp


Sponsor or person

Institute

Tokai university hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board for Clinical Research, Tokai University

Address

143 Shimokasuya, Isehara city, KANAGAWA

Tel

0463-93-1121

Email

tokai-rinsho@ml.tokai-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 09 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

13

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 12 Month 10 Day

Date of IRB

2020 Year 02 Month 03 Day

Anticipated trial start date

2020 Year 02 Month 04 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 09 Month 04 Day

Last modified on

2022 Year 03 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047550


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name